The Oneiric Activity during and after the COVID-19 Total Lockdown in Italy: A Longitudinal Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
24 03 2022
Historique:
received: 14 02 2022
revised: 18 03 2022
accepted: 22 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

A growing body of evidence highlights that the COVID-19 pandemic affected oneiric activity. However, only a few studies have assessed the longitudinal changes in dream phenomenology during different phases of the pandemic, often focused on a limited number of dream variables. The aim of the present study was to provide an exhaustive assessment of dream features during total lockdown (TL) and a post-lockdown (PL) period characterized by eased restrictive measures in Italy. We performed a longitudinal study using a web-based survey to collect demographic, COVID-19 related, clinical, sleep, and dream data at TL and PL. Our final sample included 108 participants. The high frequency of poor sleep quality, anxiety, and depressive symptoms observed during TL remained stable at PL, while sleep latency (t = −4.09; p < 0.001) and PTSD-related disruptive nocturnal behaviors (t = −5.68; p < 0.001) exhibited a reduction at PL. A PL decrease in time spent with digital media was observed (t = −2.77; p = 0.007). We found a strong PL reduction in dream frequency (t = −5.49; p < 0.001), emotional load (t = −2.71; p = 0.008), vividness (t = −4.90; p < 0.001), bizarreness (t = −4.05; p < 0.001), length (t = −4.67; p < 0.001), and lucid dream frequency (t = −2.40; p = 0.018). Fear was the most frequently reported emotion in dreams at TL (26.9%) and PL (22.2%). Only the frequency of specific lockdown-related dream contents exhibited a reduction at PL. These findings highlight that the end of the home confinement had a strong impact on the oneiric activity, in the direction of reduced dream frequency, intensity, and lockdown-related contents. The co-occurrence of such changes with a decline in nocturnal PTSD-related symptoms, sleep latency, and time with digital media suggests an influence of post-traumatic stress levels, lifestyle modifications, and sleep pattern on dream changes during different phases of the pandemic. The stable prevalence of fear in dreams and the large frequency of poor sleep quality, depressive symptoms, and anxiety are probably related to the persistence of many negative consequences of the pandemic. Overall, these results are consistent with the continuity hypothesis of dreams.

Identifiants

pubmed: 35409540
pii: ijerph19073857
doi: 10.3390/ijerph19073857
pmc: PMC8997831
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Emotion. 2001 Sep;1(3):300-19
pubmed: 12934688
J Sleep Res. 2021 Oct;30(5):e13368
pubmed: 33955081
Sleep Med. 2021 May;81:20-32
pubmed: 33631710
J Sleep Res. 2022 Feb;31(1):e13425
pubmed: 34159658
J Sleep Res. 2022 Apr;31(2):e13500
pubmed: 34595786
Confl Health. 2012 Jul 30;6(1):4
pubmed: 22846511
Front Psychol. 2020 Nov 09;11:574475
pubmed: 33304294
J Anxiety Disord. 2005;19(2):233-44
pubmed: 15533706
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Front Psychol. 2021 May 26;12:681569
pubmed: 34122276
PLoS One. 2013;8(2):e55936
pubmed: 23418478
Nature. 2005 Oct 27;437(7063):1286-9
pubmed: 16251954
Disaster Med Public Health Prep. 2013 Aug;7(4):380-6
pubmed: 24229521
J Sleep Res. 2020 Aug;29(4):e13074
pubmed: 32410272
J Sleep Res. 2021 Oct;30(5):e13300
pubmed: 33547703
Nat Sci Sleep. 2022 Jan 24;14:93-108
pubmed: 35115852
Neuropsychologia. 2012 Jun;50(7):1578-93
pubmed: 22450197
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Disasters. 2008 Jun;32(2):280-91
pubmed: 18380855
Cyberpsychol Behav Soc Netw. 2019 Oct;22(10):657-661
pubmed: 31580735
Front Psychol. 2020 Oct 01;11:573961
pubmed: 33117240
J Sleep Res. 2008 Jun;17(2):125-31
pubmed: 18355162
Front Psychol. 2019 Mar 15;10:459
pubmed: 30930809
BMJ Open. 2021 Dec 13;11(12):e050672
pubmed: 34903540
J Sleep Res. 2022 Feb;31(1):e13439
pubmed: 34409676
Nat Sci Sleep. 2022 Jan 06;14:41-51
pubmed: 35023980
J Clin Sleep Med. 2021 Feb 1;17(2):299-313
pubmed: 33108269
Front Neurol. 2012 Jul 04;3:106
pubmed: 22783222
Sleep. 2006 Jan;29(1):85-93
pubmed: 16453985
Behav Brain Res. 2010 Jan 20;206(2):293-8
pubmed: 19788898
Nat Sci Sleep. 2021 Oct 06;13:1711-1722
pubmed: 34675720
Brain Sci. 2020 Jun 03;10(6):
pubmed: 32503215
Brain Topogr. 2017 Sep;30(5):629-638
pubmed: 28434101
Int J Environ Res Public Health. 2020 Oct 23;17(21):
pubmed: 33113914
Neurol Sci. 2013 Apr;34(4):511-9
pubmed: 22526760
Front Psychol. 2015 Aug 18;6:1132
pubmed: 26347669
PLoS One. 2020 Nov 30;15(11):e0242903
pubmed: 33253274
Front Neurol. 2017 Jun 01;8:201
pubmed: 28620339
Front Psychol. 2019 Nov 26;10:2618
pubmed: 31849749
Arch Womens Ment Health. 2012 Feb;15(1):49-55
pubmed: 22249399
Sleep Med. 2021 Dec;88:46-57
pubmed: 34731828
Am J Psychiatry. 1962 Oct;119:317-22
pubmed: 13862087
Brain Sci. 2021 Feb 11;11(2):
pubmed: 33670180
Hum Brain Mapp. 2011 Sep;32(9):1458-70
pubmed: 20740648
Mil Med. 2012 May;177(5):501-6
pubmed: 22645874
Disaster Manag Response. 2006 Jan-Mar;4(1):12-8
pubmed: 16360635
PLoS One. 2021 Nov 24;16(11):e0259040
pubmed: 34818346
Brain Sci. 2021 Nov 17;11(11):
pubmed: 34827519
PLoS One. 2020 May 14;15(5):e0233410
pubmed: 32407409
Brain Sci. 2021 Oct 20;11(11):
pubmed: 34827374
Sleep Med. 2020 Nov;75:12-20
pubmed: 32853913
Psychosom Med. 2003 Mar-Apr;65(2):301-6
pubmed: 12651998
Nat Sci Sleep. 2021 Sep 22;13:1573-1591
pubmed: 34588830
Sleep Med. 2021 Nov;87:38-45
pubmed: 34508986
J Sleep Res. 2021 Oct;30(5):e13313
pubmed: 33687798
Res Psychother. 2021 Aug 24;24(2):547
pubmed: 34568113
Sleep Med X. 2021 Jan 12;3:100032
pubmed: 33870179
Brain Topogr. 2010 Mar;23(1):27-40
pubmed: 20043199
J Consult Clin Psychol. 1974 Oct;42(5):699-703
pubmed: 4372256
Psychol Med. 2020 Nov 13;:1-10
pubmed: 33183370
Am J Psychiatry. 1963 Apr;119:913-21
pubmed: 13929753
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
J Abnorm Psychol. 1992 May;101(2):219-24
pubmed: 1583211
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Neurobiol Learn Mem. 2015 Jul;122:98-109
pubmed: 25683202
J Sleep Res. 2022 Feb;31(1):e13429
pubmed: 34288197
J Clin Sleep Med. 2019 Sep 15;15(9):1209-1215
pubmed: 31538591
Front Psychol. 2021 Mar 05;12:644636
pubmed: 33746860
Front Psychiatry. 2021 Mar 30;12:625973
pubmed: 33859579

Auteurs

Maurizio Gorgoni (M)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.
Body and Action Lab, IRCSS Fondazione Santa Lucia, 00179 Rome, Italy.

Serena Scarpelli (S)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Valentina Alfonsi (V)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Ludovica Annarumma (L)

Body and Action Lab, IRCSS Fondazione Santa Lucia, 00179 Rome, Italy.

Elisa Pellegrini (E)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Elisabetta Fasiello (E)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Susanna Cordone (S)

Faculty of Medicine, UniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.

Aurora D'Atri (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Federico Salfi (F)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Giulia Amicucci (G)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Michele Ferrara (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

Mariella Pazzaglia (M)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.
Body and Action Lab, IRCSS Fondazione Santa Lucia, 00179 Rome, Italy.

Luigi De Gennaro (L)

Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy.
Body and Action Lab, IRCSS Fondazione Santa Lucia, 00179 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH